Journals / İstanbul Kanuni Sultan Süleyman Tıp Dergisi / 2021 / Cilt: 13 - Sayı: 3

COVID-19 in Hemodialysis Patients: Clinical Features, Results, and Factors Associated with Mortality

Hemodiyaliz Hastalarında COVID-19 Enfeksiyonu: Klinik Özellikler, Sonuçlar ve Mortalite İlişkili Faktörler

Pages
162–169
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This study contributes to literature by determining biomarkers to predict mortality due to COVID-19 infection in high-risk and vulnerable HD patient population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Globally, coronavirus disease-2019 (COVID-19) has affected the elderly population and patients with multiple comorbid diseases.
📊
Key Findings & Data:Hemodialysis (HD) patients are at risk of contracting COVID-19 due to immunosuppression caused by chronic kidney disease, advanced age, and existing comorbid diseases.
💡
Conclusion & Impact:Conclusion: This study contributes to literature by determining biomarkers to predict mortality due to COVID-19 infection in high-risk and vulnerable HD patient population.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Globally, coronavirus disease-2019 (COVID-19) has affected the elderly population and patients with multiple comorbid diseases. Hemodialysis (HD) patients are at risk of contracting COVID-19 due to immunosuppression caused by chronic kidney disease, advanced age, and existing comorbid diseases. We retrospectively studied the clinical characteristics of total of 121 HD patients with COVID-19. Method: A total of 121 HD patients who met the COVID-19 probable case definition were included in the study. The patients were divided into groups according to their clinical and laboratory findings: mild-moderate, severe, and critical. Subsequently, the patients were divided into classified as either survivors or nonsurvivors and their demographic and laboratory data were compared. Results: Of the 121 patients, 61 (51%) and 59 (49%) were female and male, respectively. Mean age of the patients was 61 ± 14. The most common comorbid disease among the patients was hypertension, followed by coronary artery disease and diabetes mellitus. The most common complaints were cough, myalgia, and shortness of breath. Conclusion: This study contributes to literature by determining biomarkers to predict mortality due to COVID-19 infection in high-risk and vulnerable HD patient population.

Özet

Amaç: Koronavirüs hastalığı-2019 (COVID-19) enfeksiyonu tüm dünyada, yaşlı popülasyonu ve birçok komorbid hastalığı olan hastaları etkilemiştir. Hemodiyaliz (HD) hastaları, ileri yaş, mevcut komorbid hastalıklar ve kronik böbrek hastalığının, neden olduğu immünosupresyon nedeniyle COVID-19 enfeksiyonu için riski altındadır. Çalışmamızda COVID-19 enfeksiyonu olan 121 HD hastasının klinik özellikleri, sonuçları ve mortalite ile ilişkili faktörleri inceledik. Yöntem: COVID-19 olası olgu tanımına uyan 121 hemodiyaliz hastası çalışmaya dahil edildi. Hastalar klinik ve laboratuvar özelliklerine göre hafif-orta, ağır ve kritik olarak gruplara ayrıldı. Daha sonra hastalar sağ kalanlar ve eksitus olanlar olarak gruplara ayrılarak demografik ve laboratuvar verileri açısından karşılaştırıldı. Bulgular: Çalışmaya 61’i (% 51) kadın, 59’u (%49) erkek olmak üzere toplam 121 hasta dahil edildi. Hastaların ortalama yaşı 61 ± 14 idi. Hastaların en sık eşlik eden komorbid hastalığı hipertansiyon, ardından koroner arter hastalığı ve diabetes mellitus idi. En yaygın şikayetler öksürük, kas ağrısı ve nefes darlığı idi. Sonuç: Bu çalışma, yüksek riskli ve savunmasız HD hasta popülasyonunda COVID-19 enfeksiyonuna bağlı mortaliteyi öngörmek için beyaz kan hücre sayısı, nötrofil sayısı, laktat dehidrogenaz, aspartat transaminaz gibi biyobelirteçlerin kullanımının faydalı olacağını göstermiştir.

🔖

Cite This Article

TİMUR, Ö., DEMİRCİ, R., SEVİNÇ, C. (2022). COVID-19 in Hemodialysis Patients: Clinical Features, Results, and Factors Associated with Mortality. İstanbul Kanuni Sultan Süleyman Tıp Dergisi, Cilt: 13 - Sayı: 3, 162–169. https://ajindex.com/articles/550932

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. World Health Organization. 2020. Available from: https:// covid19.who.int/ 2. Ozturk S, Turgutalp K, Arici M, et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. Nephrol Dial Transplant. 2020;35:2083-95. 3. Park HC, Lee YK, Lee SH, et al; Korean Society of Nephrology MERS-CoV Task Force Team. Middle East respiratory syndrome clinical practice guideline for hemodialysis facilities. Kidney Res Clin Pract. 2017;36:111- 6. doi: 10.23876/j.krcp.2017.36.2.111. 4. Collins AJ, Kliger AS. Urgent: stop preventable ınfections Now. Clin J Am Soc Nephrol. 2018;13:663-5. doi: 10.2215/CJN.10790917. 5. Xiong F, Tang H, Liu L, et al. Clinical characteristics of and medical ınterventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol. 2020;31:1387-97. doi: 10.1681/ASN.2020030354. 6. Scarpioni R, Manini A, Valsania T, et al. Covid-19 and its impact on nephropathic patients: the experience at Ospedale "Guglielmo da Saliceto" in Piacenza. G Ital Nefrol. 2020;37:2020-vol2. 7. Goicoechea M, Sánchez Cámara LA, Macías N, et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020;98:27-34. doi: 10.1016/j.kint.2020.04.031. 8. Valeri AM, Robbins-Juarez SY, Stevens JS, et al. Presentation and outcomes of patients with ESKD and COVID-19. J Am Soc Nephrol. 2020;Jul;31:1409-15. doi: 10.1681/ASN.2020040470. 9. Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20. doi: 10.1056/ NEJMoa2002032. 10. Chen CY, Shao SC, Chen YT, et al. Incidence and clinical ımpacts of COVID-19 ınfection in patients with hemodialysis: systematic review and meta-analysis of 396,062 hemodialysis patients. Healthcare (Basel). 2021;9:47. doi: 10.3390/healthcare9010047. 11. Stefan G, Mehedinti AM, Andreiana I, et al. Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania. Ren Fail. 2021;4349-57. doi: 10.1080/0886022X.2020.1853571 12. Ma Y, Diao B, Lv X, et al. COVID-19 in hemodialysis (HD) patients: Report from one HD center in Wuhan, China. medRxiv. 2020. doi: 10.1101/2020.02.24.20027201. 13. Shang W, Li Y, Li H, et al. Correlation between laboratory parameters on admission and outcome of